Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection
Gastón Bergero, … , Martin Rottenberg, Maria P. Aoki
Gastón Bergero, … , Martin Rottenberg, Maria P. Aoki
Published July 1, 2025
Citation Information: J Clin Invest. 2025;135(13):e186785. https://doi.org/10.1172/JCI186785.
View: Text | PDF
Research Article Immunology Infectious disease Inflammation

Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection

  • Text
  • PDF
Abstract

Chagas disease, caused by Trypanosoma cruzi, is endemic to Latin America and is characterized by chronic inflammation of cardiac tissues due to parasite persistence. Hypoxia within infected tissues may trigger the stabilization of HIF-1 and be linked to ATP release. Extracellular ATP exhibits microbicidal effects but is scavenged by CD39 and CD73 ectonucleotidases, which ultimately generate adenosine (ADO), a potent immunosuppressor. Here, we comprehensively study the importance of HIF-1 stabilization and the CD39/CD73/ADO axis, on CD4+ T cells with the cytotoxic phenotype, in facilitating the persistence of T. cruzi. Myocardial infection induces prominent areas of hypoxia, which is concomitant with HIF-1α stabilization in T cells and linked to early expansion of CD39+CD73+CD4+ T cell infiltrating population. Functional assays further demonstrate that HIF-1 stabilization and CD73 activity are associated with impaired CD4+ T cell cytotoxic potential. RNA-Seq analysis reveals that HIF-1 and purinergic signaling pathways are overrepresented in cardiac tissues of patients with end-stage Chagas disease. The findings highlight a major effect of purinergic signaling on CD4+ T cells with potential cytotoxic capacity in the setting of T. cruzi infection and have translational implications for therapy.

Authors

Gastón Bergero, Yanina L. Mazzocco, Sebastian Del Rosso, Ruining Liu, Zoé M. Cejas Gallardo, Simon C. Robson, Martin Rottenberg, Maria P. Aoki

×

Figure 2

Extracellular ATP and ADO differentially impact CD4+ T cell activation and proliferation.

Options: View larger image (or click on image) Download as PowerPoint
Extracellular ATP and ADO differentially impact CD4+ T cell activation a...
(A–D) Naive CD4+ T cells were stimulated with anti-CD3/CD28 antibodies and supplemented with ATP (250 nM) or ADO (500 μM) for 72 hours (n = 4 per group). Representative dot plots and percentages of blasts (A), activation surface markers CD44+CD69+ (B), and CD25+ (C) in CD4+ T cells. (D) Representative histograms and quantification of the proliferation rate via CFSE dilution of CD4+ T cells. (E–G) CD4+ T cells were stimulated with anti-CD3/CD28 antibodies and supplemented with ATP, ADO, A2aR inhibitor ZM-241385 (1 μM), or P2X7R inhibitor A-438079 (25 μM) or maintained in medium alone for 72 hours (n = 3 per group). UMAP plots (E) and percentages and MFIs of granzyme B (F) and IFN-γ (G) expression in CD4+ T cells. One-way ANOVA followed by Tukey’s post hoc test was conducted for A–G. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts